The available protocols do not operate via this mechanism.
The resilience of remaining hair is also totally irrelevant here.
Your analogy is completely off.
Because this therapy is akin to regrowing a whole finger.
That is relevant to therapies which seek to revitalize or maintain existing hair.
There is no hard evidence that neogenesis is less likely in slick bald areas
No, again you're comparing apples to coconuts and once again missing the fact that this isn't innately a one-and-done treatment. The patent on the device includes an attachment that allows you to bypass existing hair.
There is, however — due to the body's healing response — reason to assume that the treatment may not be as effective on many older patients.
You're also operating under the assumption that a lower cm2 amount of hair is somehow more acceptable on lower norwoods; it's not, as it would leave you diffuse regardless of whether you're NW7 or 1. If this thing only produced diffuse amounts of hair, then it is not a viable option for those with receding hairlines — it's target demographic.
Goal post: Follica will only be good for gaining a couple of norwoods or lower-tier norwoods
- Since the concept of the treatment is to grow new follicles wherever it is applied (the process is repeatable) and we have no evidence suggesting that this treatment is less effective in particular areas or after a certain passage of time (in young patients), and a diffuse amount is unfavorable at any hairloss stage, it is therefore unreasonable to assume that the treatment's utility is limited by the amount of hair one already has instead of other biological factors.
Well, we'll have to wait (about two years or so) and see. But the facts we know - the data we actually have - says 25 terminal hairs per cm^2, and their optimization study is focusing on mid NWs, not high ones. There must be a reason they gave that number and chose that cohort profile, and if it was the case that results could be compounded to a more natural 140-200 hairs per cm^2 on high NWs, they would have said - or alluded to - as much. I hope you're right, but all research to date says you're not. That's not to say it could change; this is Follica V.01 - they will be fine-tuning it for the next ten to twenty years, adding new compounds as they are cleared, applying new techniques developed from data gathered from commercial patients, applying AI deep learning to greater data sets, etc. I would be surprised if it couldn't some day grow significantly more hair than it can now, just not on its first day of commercialization.
Follica definitely sounds appealing. My concern however is: will the population that cant use minoxidil and finasteride be at a loss once again with this product? Seems like their future compounds wont he released for many many years as there compounds are in pre clinical stage.
They have said in the past that this will be an adjunct therapy to those already available, and that it would work in conjuncture with minoxidil/finasteride (https://www.hairlosstalk.com/news/new-research/follica-presents-at-the-aad-2017-annual-meeting/ : "Treatment modality not the same as minoxidil/finasteride, so they would most likely not discourage people from stopping their current treatments"). Given that, I believe that the new hair will be as dht-sensitive as the patient's miniaturized hair.
My only caution to this...... while everything you’ve said maybe correct, our own experiences as it relates to dermarolling on our own have shown that it is the higher norwoods with more substantial loss and diffuse thinners that are far advanced, that respond most favorably. At least as it relates to the most drastic of meddling recoveries. The guys that have mild recession, or are just starting to thin, they seem to be the guys for which it doesn’t work. That one makes me shake my head.
I don't give much credence to anything claimed on the forums, and the modality - simple rolling with or without minoxidil - is very different than what Follica has developed. The key to Follica's value isn't in the wound response, it's the precision with which they've harnessed it. They have spent 15 years studying this phenomena, and are finally coming to market after feeling satisfied that they have perfected every aspect of it - depth, frequencies, windows, etc. There are just so many factors to the wound response that have to be accounted for and manipulated that no home roller could possibly stumble upon all of them. This is why I haven't tried it myself - I am too afraid that I would end up doing more harm than good, since the protocols developed by the handful of available studies are very unsophisticated in comparison to what Follica has achieved.
Last edited: